Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 31, 2026
Why Is Linde plc (LIN) Stock Down -5.60% Today?

Why Is Linde plc (LIN) Stock Down -5.60% Today?

Key Takeaways

  • Linde plc shares tumbled approximately 5.60% in Friday's session, making it one of the steepest single-day declines for the industrial gas giant in recent months.
  • The primary catalyst was disappointing forward guidance: the company's Q3 2026 EPS outlook of $4.45–$4.55 came in below the $4.59 analyst consensus, overshadowing an otherwise solid Q2 report.
  • Q2 adjusted EPS of $4.50 met expectations and revenue of $9.3 billion actually exceeded estimates, but margin compression and cautious commentary around European demand weighed on sentiment.
  • The stock broke below both its 50-day and 200-day moving averages, technical levels that traders had been closely monitoring.
  • Broader market conditions were mixed, but sector-specific concerns around industrial cyclical demand and elevated capital spending plans added to the selling pressure.

Opening Summary

LIN — Linde plc, the world's largest industrial gas company — saw its stock plunge approximately 5.60% on Friday, July 31, 2026. Shares fell from a previous close of $508.64 to trade near $480.14 in the afternoon session, as investors reacted sharply to the company's second-quarter earnings release and, more critically, guidance that fell short of Wall Street consensus. The sell-off erased roughly $13 billion in market capitalization from the $235 billion industrial heavyweight, marking one of the most significant single-day reactions to a Linde earnings report in years.

Earnings Beat Overshadowed by Soft Guidance

Linde's second-quarter results were, on the surface, perfectly respectable. The company reported adjusted earnings per share of $4.50, in line with analyst expectations of $4.49. Revenue came in at $9.3 billion, handily exceeding the consensus estimate of $9.02 billion and representing 9% year-over-year growth. Operating cash flow reached $2.3 billion, up 3% from the prior year, and the company maintained industry-leading adjusted operating margins of 29.5%. CEO Sanjiv Lamba highlighted "record sales and EPS" alongside a project backlog that swelled to $11 billion.

However, the market zeroed in on what came next. For the third quarter of 2026, Linde guided for adjusted EPS in the range of $4.45 to $4.55 — below the Street's $4.59 consensus. Full-year 2026 guidance was set at $17.70 to $17.90, also marginally below the $17.91 analyst estimate. While the midpoint of the full-year range implies 8% to 9% year-over-year EPS growth, the guidance shortfall relative to consensus rattled investors who had grown accustomed to Linde consistently exceeding expectations.

Margin Pressure and Regional Weakness

Deeper scrutiny of the earnings release reveals additional concerns that likely fueled the sell-off. Adjusted operating margin compressed by 60 basis points compared to the prior year, as cost inflation offset gains from higher pricing and productivity initiatives. Across all three geographic segments — Americas, APAC, and EMEA — operating margins declined year-over-year on a reported basis. The EMEA region was particularly soft, with underlying sales growth of just 1%, driven entirely by pricing as volumes contracted in the manufacturing end market. This regional weakness echoes broader macroeconomic anxieties about industrial demand in Europe.

Compounding the margin narrative, Linde's full-year capital expenditure guidance of $5.5 billion to $6.0 billion — earmarked to support its record $8.1 billion contractual sale-of-gas backlog — signaled that elevated spending will persist, potentially pressuring free cash flow in the near term.

Market Context and Trading Activity

The magnitude of Friday's decline was amplified by the stock's positioning coming into the quarter. LIN had been trading near the upper end of its 52-week range, with shares having reached an all-time high of $548.20 earlier in July. The stock's 50-day moving average of approximately $516 had provided support in recent sessions, but Friday's plunge drove shares decisively below both that level and the 200-day moving average near $496 — a bearish technical signal that likely triggered additional algorithmic and momentum-driven selling.

Trading volume surged well above the daily average, reflecting the intensity of the re-rating. The move was largely company-specific rather than macro-driven; broader equity indices were mixed, and peers in the specialty chemicals and industrial gases space did not experience the same degree of selling, suggesting that the reaction was tied squarely to Linde's guidance disappointment and premium valuation — the stock entered the session trading at roughly 34 times trailing earnings.

What Comes Next for LIN

Looking ahead, Linde's investment narrative now hinges on execution against its ambitious backlog. The company highlighted "robust customer proposal activity," particularly in the electronics end market, and announced a new $1 billion ultra-high-purity gas supply agreement supporting semiconductor manufacturing expansion in Arizona. These secular growth drivers around advanced chips and clean energy remain intact. However, investors will be closely monitoring whether cost inflation continues to outpace pricing gains, whether EMEA volumes stabilize, and whether the company's elevated capex translates into the revenue growth needed to justify its premium multiple. The next major catalyst will be the third-quarter earnings report, where management will need to demonstrate that the guidance softness was conservative rather than a harbinger of slowing momentum.

Trending AI Robots

For traders seeking to navigate volatile market conditions with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron provides hundreds of algorithmic trading bots covering thousands of tickers, but only those demonstrating the strongest performance under current market conditions are featured in this dynamically updated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing traders to identify approaches that align with their own risk profiles and objectives. Explore the Trending AI Robots page to discover which strategies are currently delivering results.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LIN

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


LIN sees its Stochastic Oscillator climbs out of oversold territory

On August 05, 2026, the Stochastic Oscillator for LIN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 53 instances where the indicator left the oversold zone. In of the 53 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LIN's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LIN advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

LIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LIN as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LIN turned negative on July 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

LIN moved below its 50-day moving average on July 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LIN crossed bearishly below the 50-day moving average on July 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LIN entered a downward trend on August 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.656) is normal, around the industry mean (7.187). P/E Ratio (30.931) is within average values for comparable stocks, (38.851). Projected Growth (PEG Ratio) (2.045) is also within normal values, averaging (2.412). Dividend Yield (0.013) settles around the average of (0.019) among similar stocks. P/S Ratio (6.321) is also within normal values, averaging (98.543).

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 12B. The market cap for tickers in the group ranges from 47 to 221.01B. LIN holds the highest valuation in this group at 221.01B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was 1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 6%. STDN experienced the highest price growth at 39%, while SNES experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -19% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 57
Price Growth Rating: 51
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
LIN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of industrial gas

Industry ChemicalsSpecialty

Profile
Details
Industry
Chemicals Specialty
Address
10 Riverview Drive
Phone
+1 203 837-2000
Employees
65177
Web
https://www.linde.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.